Evidence map›Paper›PMID 40114198›Full record

ArticleMolecular neurodegeneration2025

A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies.

David J Koss, Olivia Todd, Hariharan Menon, Zoe Anderson, Tamsin Yang, Lucas Findlay, Ben Graham, Pawel Palmowski, Andrew Porter, Nicola Morrice and 7 more

Abstract read
In one paragraph

Article in Molecular neurodegeneration, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

David J KossDivision of Neuroscience, School of Medicine, University of Dundee, Dundee, UK. DKoss001@dundee.ac.uk.ORCID 0000-0002-8034-9880
Olivia ToddTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Hariharan MenonTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Zoe AndersonTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Tamsin YangTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Lucas FindlayDivision of Neuroscience, School of Medicine, University of Dundee, Dundee, UK.
Ben GrahamDivision of Neuroscience, School of Medicine, University of Dundee, Dundee, UK.
Pawel PalmowskiNewcastle University Protein and Proteome Analysis Unit, Newcastle University, Newcastle Upon Tyne, UK.
Andrew PorterNewcastle University Protein and Proteome Analysis Unit, Newcastle University, Newcastle Upon Tyne, UK.
Nicola MorriceDivision of Neuroscience, School of Medicine, University of Dundee, Dundee, UK.
Lauren WalkerTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Johannes AttemsTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Simona S GhanemNeurological Disorders Research Centre, Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar.
Omar El-AgnafNeurological Disorders Research Centre, Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar.
Fiona En LeBeauFaculty of Medical Sciences, Biosciences Institute, Newcastle University, Newcastle, UK.
Daniel ErskineTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Tiago F OuteiroTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK. Tiago.outeiro@newcastle.ac.uk.

Funding

The Lewy Body Society (UK) LBS-0007
6 · The paper itself

Abstract

backgroundDNA damage and DNA damage repair (DDR) dysfunction are insults with broad implications for cellular physiology and have been implicated in various neurodegenerative diseases. Alpha-synuclein (aSyn), a pre-synaptic and nuclear protein associated with neurodegenerative disorders known as synucleinopathies, has been associated with DNA double strand break (DSB) repair. However, although nuclear aSyn pathology has been observed in cortical tissue of dementia with Lewy body (DLB) cases, whether such nuclear pathology coincides with the occurrence of DNA damage has not previously been investigated. Moreover, the specific types of DNA damage elevated in DLB cases and the contribution of DNA damage towards Lewy body (LB) formation is unknown.

methodsDNA damage and aSyn pathology were assessed in fixed lateral temporal cortex from clinically and neuropathologically confirmed DLB cases and controls, as well as in cortical tissue from young 3-month-old presymptomatic A30P-aSyn mice. Frozen lateral temporal cortex from DLB and control cases was subject to nuclear isolation, western blotting, aSyn seed amplification and proteomic characterisation via mass spectrometry.

resultsWe detected seed-competent nuclear aSyn, and elevated nuclear serine-129 phosphorylation in DLB temporal cortex, alongside the accumulation of DSBs in neuronal and non-neuronal cellular populations. DNA damage was also present in cortical tissue from presymptomatic A30P mice, demonstrating it is an early insult closely associated with pathogenic aSyn. Strikingly, in postmortem DLB tissue, markers of genomic DNA damage-derived cytoplasmic DNA (CytoDNA) were evident within the majority of LBs examined. The observed cellular pathology was consistent with nuclear upregulation of associated DDR proteins, particularly those involved in base excision repair and DSB repair pathways.

conclusionsCollectively our study demonstrates the accumulation of seed-competent pathological nuclear associated aSyn, alongside nuclear DNA damage and the potential involvement of DNA damage derived cytoDNA species in cytoplasmic aSyn pathology. Ultimately, our study supports the hypothesis of a reciprocal relationship between aSyn pathology and nuclear DNA damage and highlights a potential underlying role for DNA damage in pathological mechanisms relevant to DLB, as well as other synucleinopathies, opening novel possibilities for diagnosis and treatment.

Indexed as

alpha-SynucleinDNA DamageLewy Body DiseaseAgedAged, 80 and overAnimalsBiomarkersFemaleHumansLewy BodiesMaleMiceMice, Transgenicalpha-SynucleinBiomarkersAlpha-synuclein; DNA damage; synucleinopathy; Parkinson’s diseaseDementia with Lewy bodies

Identifiers

PMID40114198
PMCPMC11927131

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.